These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


52 related items for PubMed ID: 11761960

  • 1. [3D-MR angiography(MRA)].
    Sadaoka S.
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():296-8. PubMed ID: 11761960
    [No Abstract] [Full Text] [Related]

  • 2. [Portal vein involvement by hepatocellular carcinoma: diagnosis with three-dimensional contrast-enhanced MR angiography].
    Lin J, Zhou KR, Wang JH, Yan ZP.
    Zhonghua Yi Xue Za Zhi; 2005 Feb 02; 85(5):308-12. PubMed ID: 15854505
    [Abstract] [Full Text] [Related]

  • 3. [Ultrafast contrast-enhanced 3D MR angiography in the preoperative diagnosis of liver tumors].
    Misri H, Pöckler-Schöniger C, Gaa J, Georgi M, Sturm J, Ihle V.
    Rofo; 1998 Sep 02; 169(3):278-83. PubMed ID: 9779068
    [Abstract] [Full Text] [Related]

  • 4. [Three-dimensional reconstruction and image fusion between liver focal lesions and dynamic contrast-enhanced magnetic resonance angiography].
    Li Y, Liang BL, Zhang R, Xu XM, Ren JJ, Ye RX, Zhong JL.
    Ai Zheng; 2006 Jul 02; 25(7):888-91. PubMed ID: 16831284
    [Abstract] [Full Text] [Related]

  • 5. The role of time-resolved 3D contrast-enhanced MR angiography in the assessment and grading of cerebral arteriovenous malformations.
    Oleaga L, Dalal SS, Weigele JB, Hurst RW, Lee J, Voorhees A, Melhem ER.
    Eur J Radiol; 2010 Jun 02; 74(3):e117-21. PubMed ID: 19467814
    [Abstract] [Full Text] [Related]

  • 6. Optimal multi-phase three-dimensional fast imaging with steady-state free precession dynamic MRI and its clinical application to the diagnosis of hepatocellular carcinoma.
    Shinozaki K, Honda H, Yoshimitsu K, Taguchi K, Kuroiwa T, Irie H, Aibe H, Nishie A, Nakayama T, Shimada M, Masuda K.
    Radiat Med; 2002 Jun 02; 20(3):111-9. PubMed ID: 12126083
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Low-dose, time-resolved, contrast-enhanced 3D MR angiography in the assessment of the abdominal aorta and its major branches at 3 Tesla.
    Kramer U, Fenchel M, Laub G, Seeger A, Klumpp B, Bretschneider C, Finn JP, Claussen CD, Miller S.
    Acad Radiol; 2010 May 02; 17(5):564-76. PubMed ID: 20171907
    [Abstract] [Full Text] [Related]

  • 9. Gadopentetate dimeglumine-enhanced three-dimensional MR-angiography: dosing, safety, and efficacy.
    Goyen M, Debatin JF.
    J Magn Reson Imaging; 2004 Mar 02; 19(3):261-73. PubMed ID: 14994293
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of gadodiamide (Gd-DTPA-BMA) in renal 3D-magnetic resonance angiography (MRA): a phase II study.
    Kittner T, Rudolf J, Fages JF, Legmann P, Aschauer M, Repa I, Alvares MR, Savalegui I, Ittrich H, Geterud K, de Kevviler E, Ayuso J, Lockhart ME, Blum A, Iliasch H, Leisinger G, van Beek EJ, Reid AW, Brown JJ, Yu TC, Flamm SD, Düber C, Judmaier W, Reimer P, Stiskal M, Kramann B, Wolff S, Blankenstein C.
    Eur J Radiol; 2007 Dec 02; 64(3):456-64. PubMed ID: 17412546
    [Abstract] [Full Text] [Related]

  • 11. [MR imaging during arteriography (MR arteriography) in the detection of hepatocellular carcinoma].
    Fujita T, Choji T, Ito K, Hatanaka M, Suga K, Yoneshiro S, Matsumoto T, Nakada T, Nakanishi T.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Jun 25; 53(6):716-8. PubMed ID: 8393187
    [Abstract] [Full Text] [Related]

  • 12. Three-dimensional contrast-enhanced MR angiography in diagnosis of portal vein involvement by hepatic tumors.
    Lin J, Zhou KR, Chen ZW, Wang JH, Wu ZQ, Fan J.
    World J Gastroenterol; 2003 May 25; 9(5):1114-8. PubMed ID: 12717869
    [Abstract] [Full Text] [Related]

  • 13. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.
    Yu JS, Lee JH, Chung JJ, Kim JH, Kim KW.
    Acta Radiol; 2008 Sep 25; 49(7):735-43. PubMed ID: 18608015
    [Abstract] [Full Text] [Related]

  • 14. Time-resolved contrast-enhanced three-dimensional pulmonary MR-angiography: 1.0 M gadobutrol vs. 0.5 M gadopentetate dimeglumine.
    Fink C, Bock M, Kiessling F, Lichy MP, Krissak R, Zuna I, Schmähl A, Delorme S, Kauczor HU.
    J Magn Reson Imaging; 2004 Feb 25; 19(2):202-8. PubMed ID: 14745754
    [Abstract] [Full Text] [Related]

  • 15. Noncontrast 3D steady-state free-precession magnetic resonance angiography of the whole chest using nonselective radiofrequency excitation over a large field of view: comparison with single-phase 3D contrast-enhanced magnetic resonance angiography.
    Krishnam MS, Tomasian A, Deshpande V, Tran L, Laub G, Finn JP, Ruehm SG.
    Invest Radiol; 2008 Jun 25; 43(6):411-20. PubMed ID: 18496046
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Contrast-enhanced 3D MR voiding urethrography: preliminary results.
    Yekeler E, Suleyman E, Tunaci A, Tunaci M, Balci NC, Onem K, Tunc M, Acunas G.
    Magn Reson Imaging; 2004 Nov 25; 22(9):1193-9. PubMed ID: 15607090
    [Abstract] [Full Text] [Related]

  • 18. 3D contrast-enhanced MR angiography of the abdominal aorta and its distal branches: Interobserver agreement of radiologists in a routine examination.
    Billaud Y, Beuf O, Desjeux G, Valette PJ, Pilleul F.
    Acad Radiol; 2005 Feb 25; 12(2):155-63. PubMed ID: 15721592
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 3.